Is There a Need for Another Inhalative β2-Agonist besides Formoterol in Patients with Asthma?
- 27 July 2001
- journal article
- the opinion-corner
- Published by S. Karger AG in Respiration
- Vol. 68 (4) , 432-437
Abstract
Formoterol can substitute the rapid- and short-acting β2-agonists as well as the slow- and long-acting salmeterol. Therefore formoterol in a fixed combination with an inhalant steroid reduces the aerosol devices necessary for asthma control to only one, to be used for regular ‘controller’ and, as needed, ‘rescue therapy’. The side effect profile of formoterol is comparable to the short-acting β2-agonists which makes the combination with a topically active glucocorticoid applicable in patients of any asthma severity as long as they are able to perform an inspiratory vital capacity maneuverKeywords
This publication has 13 references indexed in Scilit:
- Evidence of the Rapid Protective Effect of Formoterol Dry-Powder Inhalation against Exercise-Induced Bronchospasm in Athletes with AsthmaRespiration, 2000
- Formoterol via Turbuhaler®gave better protection than terbutaline against repeated exercise challenge for up to 12 hours in children and adolescentsRespiratory Medicine, 2000
- Salmeterol/fluticasone propionate combination therapy 50/250 μ g twice daily is more effective than budesonide 800 μ g twice daily in treating moderate to severe asthmaRespiratory Medicine, 2000
- Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)BMJ, 2000
- Ligand-independent Activation of the Glucocorticoid Receptor by β2-Adrenergic Receptor Agonists in Primary Human Lung Fibroblasts and Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1999
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potencyEuropean Respiratory Journal, 1997
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- Regular inhaled salbutamol and airway responsiveness to allergenThe Lancet, 1993
- Regular inhaled beta-agonist treatment in bronchial asthmaThe Lancet, 1990